Is Stock Picking Impossible This Year?

 | Jul 19, 2013 | 7:00 AM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

tsla

,

vrtx

One frustration many portfolio managers are voicing -- at least the underperforming ones -- is that stock picking is impossible this year, with the Federal Reserve "manipulating" the markets.  While I do agree that the Fed is trying to steer the market to a pre-ordained outcome (using the wealth effect to drive economic growth and better employment), is it the case that stock picking is "impossible" this year?

Rather than speculate, let's go to the numbers.  I sorted all the large cap stocks (defined as greater than $5 billion market cap) by YTD total return, then looked at a couple key indicators to see what they, well, indicated about the stocks.  Growth managers often look at EPS revisions and value managers look at price-to-earnings multiple, so were these helpful in sorting out stocks to help find this year's winners?

Actually, the answer is..."hmmmm."  As it turns out, if we take the 660 large cap U.S. stocks and divide into "decile groups" -- that is, groups of 66 such that there are 10 groups -- we get an interesting outcome.  In the best performing group, the 2013 EPS estimate was revised down on average by more than 6%!  And this group started the year with an average P/E multiple of 41 times, far higher than all the other groups.  If you wanted to pick a big winner in the first half, you needed to look among the most expensive stocks, and not worry that the earnings were even improving!

Before you underperformers scream "ah ha!" study the rest of the table. Other than the top group, the rest of the universe more or less tracked as you would expect.  The second highest performing group saw its EPS estimate revised up on average, and it started the year with an ordinary multiple of 16 times.

Probably more importantly, the two worst performing groups saw their EPS estimates revised down, and they both started the year with high average multiples of 18 times and 26 times.  One way to outperform is to hit the homeruns, the other way is to avoid the losers. By avoiding high multiples you would not have owned Tesla (TSLA), but you would have also avoided many losers.  Similarly, if estimates were being revised down, you might sell a Vertex Pharma (VRTX), but you would also avoid many, many other losers.

Even when the markets are acting a bit odd, relative to the fundamentals, solid investing precepts can still work over time.

If any of you readers want the full list of names, just email me. At 660, the table is too large to post here!

Columnist Conversations

Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market gets hit from impact of sanctions against Russia for second day in row but manages to rally a bit to en...
We took out some of the high end of support, but I'm still looking at this symmetrical pullback for entries on...
going into trading today roughly 37 million shares of X (US Steel) was held short.today big X has traded 27 mi...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.